Massivit 3D Printing Technologies Ltd (MSVT) Fair Value & Analysis
Technology · Il · Market cap 29.0M ILA
Fair value as of: Jun 24, 2026
Analysis
Massivit 3D Printing Technologies Ltd (MSVT) currently trades at 0.7780 ILA, while our model-based Fair Value estimate is 0.4300 ILA — implying the stock looks roughly 44.7% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Massivit 3D Printing Technologies Ltd operates as a provider of industrial 3D printing systems in the United States, Europe, the Middle East, Africa, and the Asia-Pacific. The company offers Massivit 10000, an additive manufacturing system is designed to overcome the bottlenecks of mold production for composite manufacturing; Massivit 5000, an industrial-grade 3D printer enables ultra-fast custom manufacturing for the automotive, railway, marine and additional industries; and Massivit 3000, large-format 3D printer. It serves 3D printers for use in aerospace and defense, automotive, marine, theming and entertainment, visual communication, education and research, rail, and consumer products. Massivit 3D Printing Technologies Ltd was incorporated in 2013 and is headquartered in Lod, Israel.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Massivit 3D Printing Technologies Ltd (MSVT) undervalued?
What is the fair value of MSVT?
What is the quality score of MSVT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.